Philogen S.p.A. (BIT:PHIL)
Italy · Delayed Price · Currency is EUR 23.20
+0.20 (0.87%)
Sep 4, 2025, 12:37 PM CET
Philogen Revenue
In the year 2024, Philogen had annual revenue of 77.65M EUR with 213.99% growth. Philogen had revenue of 76.14M in the half year ending December 31, 2024, with 1,003.42% growth.
Revenue
77.65M
Revenue Growth
+213.99%
P/S Ratio
11.95
Revenue / Employee
424.33K
Employees
183
Market Cap
927.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77.65M | 52.92M | 213.99% |
| Dec 31, 2023 | 24.73M | -2.21M | -8.20% |
| Dec 31, 2022 | 26.94M | 21.98M | 442.71% |
| Dec 31, 2021 | 4.96M | -1.38M | -21.77% |
| Dec 31, 2020 | 6.35M | -8.71M | -57.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.48B |
| DiaSorin | 1.22B |
| Amplifon | 2.41B |
| EL.En. | 577.19M |
| Safilo Group | 998.89M |
| GPI S.p.A. | 509.93M |
| Pharmanutra | 118.93M |
| Garofalo Health Care | 470.20M |